is there still a semaglutide shortage The weight loss drug over — and some patients are 'panicking' Shortage of Ozempic, other weight

In the 2026 survey 73.9% (249/337 [95% CIs 69.0-78.4%]) of patients who are eligible for a GLP-1RA who have not used these a GLP-1RA and have expressed an interest in participating in a clinical trial of a GLP-1RA

Significance statement ![Figure][1] ### Competing Interest Statement The authors have declared no competing interest

Greater knowledge of the mechanisms of fat fuel partitioning that underlie the metabolic and behavioral actions of GLP-1RAs could also provide a roadmap for the development of new or adjunctive pharmacological or other strategies for treating obesity and associated metabolic diseases," they conclude

100% science-backed, clinically tested ingredients Pendulum live-strain, anaerobic probiotics are non-GMO and third-party tested for quality including strain viability, heavy metals and more

El uso de agonistas del receptor del pptido similar al glucagn tipo 1 (GLP-1RAs, por sus siglas en ingls), utilizados para tratar la diabetes y la obesidad, podra estar asociado con un amplio espectro de efectos sobre la salud, tanto positivos como un menor riesgo de trastornos cardiometablicos como negativos un mayor riesgo de afecciones gastrointestinales o hipertensin

Semaglutide works by signaling fullness to the brain, helping manage the appetite surge and insulin resistance that accompany hormonal transition